Showing results (51-60 of 70) with videos related to
Sort By:
Pageof 7
The Journal of Clinical Investigation|October 1, 2025
SOX9 drives a stem-like transcriptional state and platinum resistance in high-grade serous ovarian cancerAlexander J Duval, Fidan Seker-Polat, Magdalena Rogozinska, et al.Gynecologic Oncology|April 18, 2012
Impact of operative start time on surgical outcomes in patients undergoing primary cytoreduction for advanced ovarian cancerEdward J Tanner, Kara C Long, Qin Zhou, et al.Gynecologic Oncology|November 17, 2015
Lymphopenia and its association with survival in patients with locally advanced cervical cancerEmily S Wu, Titilope Oduyebo, Lauren P Cobb, et al.Gynecologic Oncology|May 15, 2012
Outcomes of primary surgical cytoreduction in patients with BRCA-associated high-grade serous ovarian carcinomaDavid M Hyman, Kara C Long, Edward J Tanner, et al.Obstetrics and Gynecology|December 10, 2015
Utilization of Minimally Invasive Surgery in Endometrial Cancer Care: A Quality and Cost DisparityAmanda N Fader, R Matsuno Weise, Abdulrahman K Sinno, et al.Obstetrics and Gynecology|August 9, 2016
Disparities in Surgical Care Among Women With Endometrial CancerDiana Mannschreck, Rayna K Matsuno, James P Moriarty, et al.Cancer Research|November 11, 2020
Frizzled-7 Identifies Platinum-Tolerant Ovarian Cancer Cells Susceptible to FerroptosisYinu Wang, Guangyuan Zhao, Salvatore Condello, et al.Gynecologic Oncology|September 11, 2013
Does adjuvant chemotherapy improve survival for women with early-stage uterine leiomyosarcoma?Stephanie Ricci, Robert L Giuntoli, Eric Eisenhauer, et al.The Journal of Clinical Investigation|June 7, 2022
Epigenetic priming enhances antitumor immunity in platinum-resistant ovarian cancerSiqi Chen, Ping Xie, Matthew Cowan, et al.Gynecologic Oncology|April 18, 2018
Narcotics reduction, quality and safety in gynecologic oncology surgery in the first year of enhanced recovery after surgery protocol implementationJennifer E Bergstrom, Marla E Scott, Yewande Alimi, et al.Pageof 7